Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution.
about
A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serumShotgun proteomics in neurosciencePrinciples and applications of liquid chromatography-mass spectrometry in clinical biochemistryThe Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerProteomics for rejection diagnosis in renal transplant patients: Where are we now?Applications of targeted proteomics in systems biology and translational medicineQuantification of HER family receptors in breast cancerStructural, kinetic and proteomic characterization of acetyl phosphate-dependent bacterial protein acetylationAdvances in targeted proteomics and applications to biomedical researchMass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular diseaseTargeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patientsProteomics of citrullination in cardiovascular diseaseMass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimensDeveloping multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometryA Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo Activity against MRSA that Inhibits MenB in the Bacterial Menaquinone Biosynthesis PathwayOptimization of plasma sample pretreatment for quantitative analysis using iTRAQ labeling and LC-MALDI-TOF/TOFDesign, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS)SISCAPA peptide enrichment on magnetic beads using an in-line bead trap device.Variation and quantification among a target set of phosphopeptides in human plasma by multiple reaction monitoring and SWATH-MS2 data-independent acquisitionExtending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues.Multiplexed, Scheduled, High-Resolution Parallel Reaction Monitoring on a Full Scan QqTOF Instrument with Integrated Data-Dependent and Targeted Mass Spectrometric Workflows.Quantification of Lysine Acetylation and Succinylation Stoichiometry in Proteins Using Mass Spectrometric Data-Independent Acquisitions (SWATH)MRMer, an interactive open source and cross-platform system for data extraction and visualization of multiple reaction monitoring experimentsQuantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometryProteomic analyses of pancreatic cyst fluidsExpediting the development of targeted SRM assays: using data from shotgun proteomics to automate method development.Correlation between y-type ions observed in ion trap and triple quadrupole mass spectrometersMaRiMba: a software application for spectral library-based MRM transition list assembly.Discovery and validation of colonic tumor-associated proteins via metabolic labeling and stable isotopic dilution.Antigen identification and characterization of lung cancer specific monoclonal antibodies produced by mAb proteomics.IDPicker 2.0: Improved protein assembly with high discrimination peptide identification filtering.Rapid optimization of MRM-MS instrument parameters by subtle alteration of precursor and product m/z targets.Biomarker discovery and clinical proteomics.Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: an NCI-CPTC initiative perspective.Targeting peptide termini, a novel immunoaffinity approach to reduce complexity in mass spectrometric protein identification.Sampling the N-terminal proteome of human blood.Stable-isotope dilution LC–MS for quantitative biomarker analysis.Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry.Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.Moxifloxacin Concentration and Proteomic Analysis of Aqueous Humor in Human Uveitis Associated with Oral Moxifloxacin Therapy
P2860
Q24307894-EA0FC1E0-E348-4ACF-A0A6-0CF7F0D995D8Q24652437-235BADC3-F6D1-4BC4-B727-AE5911C08A32Q24653004-D58C8884-5045-4473-8941-E93E8C57AE30Q26738703-C1294CEF-01E6-487F-9971-27FA1298FC7DQ26751478-33608C9A-3E60-4E90-8DC4-49A7B7755D62Q26852271-B0DDEA40-209C-4DEE-A19B-D55FCA7DF739Q27015506-36B80B95-C40A-4A70-90AE-C1ABBE63E431Q27683517-1EAB13A1-0B7F-44BA-A14C-09557C29757BQ28066912-A1C432EA-570A-4920-B71B-684A1CE05501Q28075372-9E4BC7A0-0494-40F5-ACE8-40AA5E42D3E8Q28085015-EA0359C9-6673-49AD-A67F-6A2B117B5089Q28242377-3CBB86A1-F24C-488E-A40F-F8BF5AE98A3FQ28307595-81EEB795-442C-40E9-AFB8-CC6703AF1E2FQ28395328-740B14DE-8DD1-4182-BF16-E0483FEDC5E5Q28396297-2AE2DF18-33C3-4EF3-98E0-FB3F5C12C768Q28540277-F0679387-44B5-4D98-AD95-A8335932F865Q28681060-34DAC742-759A-43DD-AFF9-1C013D6C21B6Q30487950-58B74310-6EE2-40D6-99AE-F0ABAF1EDBC5Q30826158-6F1F6B26-2533-44F3-8F52-DE9FB0EA8C7EQ30901756-0A17BAF5-148D-4AAB-B8AA-D9D7F14AA5CBQ30996203-A46EA0BA-5F9E-4D65-ADC6-AF9E628A06B4Q31126463-86650D20-7EB8-43A7-89FD-672F84AB0185Q31163848-F3D6F6BE-6B45-4270-BD1C-7CC690F47C3FQ33370510-45B2E14E-1E02-42D1-A4DE-4B1EE01FA2FFQ33399055-F1C384E3-6693-4826-B434-6F8A00500A88Q33423155-27EC7C9F-558F-4524-B9FE-665E5DCD09B5Q33482345-02275C3B-4239-4FA7-9B38-6E3F9D275266Q33482354-D402A0AF-B409-4D62-BA7B-9A58E2798C03Q33508740-AC5FF575-1636-4E67-AD19-E978D3C81D72Q33530521-16C7EFD8-D538-479E-9A8A-06216429B767Q33607524-2E9B9DED-74EF-4B47-924E-DC5D5CCF8938Q33611832-4D64827C-6A13-4B0E-8907-83370D201E29Q33655101-3AC10141-7FA7-48BB-AAFE-2318F37E7566Q33669587-C3660DCC-E9E6-4643-8BBD-E7088DB07A33Q33723801-4DCC9B26-C3EB-4418-8632-EAD936A8BD20Q33740667-5F09B81E-4AE5-4423-8917-E9729A5E93D3Q33747062-A331555A-10C4-4E36-854F-A9F1D77904ACQ33775524-FCF1CD70-E78D-45B4-B002-8A4127C6CB70Q33794491-7940A2B1-8404-4546-99E7-B91C5CBD9BFEQ33826630-CDF4813B-0B3B-49A6-9F21-7C42E6D930E0
P2860
Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Quantitative, multiplexed assa ...... y and stable isotope dilution.
@ast
Quantitative, multiplexed assa ...... y and stable isotope dilution.
@en
type
label
Quantitative, multiplexed assa ...... y and stable isotope dilution.
@ast
Quantitative, multiplexed assa ...... y and stable isotope dilution.
@en
prefLabel
Quantitative, multiplexed assa ...... y and stable isotope dilution.
@ast
Quantitative, multiplexed assa ...... y and stable isotope dilution.
@en
P2093
P2860
P1476
Quantitative, multiplexed assa ...... y and stable isotope dilution.
@en
P2093
Hasmik Keshishian
Michael Burgess
Steven A Carr
Terri Addona
P2860
P304
P356
10.1074/MCP.M700354-MCP200
P577
2007-10-15T00:00:00Z